rs151115064

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3_ModeratePP5

The NM_001232.4(CASQ2):​c.748C>T​(p.Arg250Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000638 in 1,457,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000075 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000063 ( 0 hom. )

Consequence

CASQ2
NM_001232.4 missense

Scores

12
5
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:3

Conservation

PhyloP100: 2.68

Publications

6 publications found
Variant links:
Genes affected
CASQ2 (HGNC:1513): (calsequestrin 2) The protein encoded by this gene specifies the cardiac muscle family member of the calsequestrin family. Calsequestrin is localized to the sarcoplasmic reticulum in cardiac and slow skeletal muscle cells. The protein is a calcium binding protein that stores calcium for muscle function. Mutations in this gene cause stress-induced polymorphic ventricular tachycardia, also referred to as catecholaminergic polymorphic ventricular tachycardia 2 (CPVT2), a disease characterized by bidirectional ventricular tachycardia that may lead to cardiac arrest. [provided by RefSeq, Jul 2008]
CASQ2 Gene-Disease associations (from GenCC):
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia 2
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Genomics England PanelApp
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.904
PP5
Variant 1-115725543-G-A is Pathogenic according to our data. Variant chr1-115725543-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 572954.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASQ2NM_001232.4 linkc.748C>T p.Arg250Cys missense_variant Exon 7 of 11 ENST00000261448.6 NP_001223.2 O14958-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASQ2ENST00000261448.6 linkc.748C>T p.Arg250Cys missense_variant Exon 7 of 11 1 NM_001232.4 ENSP00000261448.5 O14958-1

Frequencies

GnomAD3 genomes
AF:
0.0000746
AC:
10
AN:
134050
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000116
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000924
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000528
AC:
13
AN:
246390
AF XY:
0.0000375
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.0000879
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000551
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000629
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000627
AC:
83
AN:
1323916
Hom.:
0
Cov.:
47
AF XY:
0.0000587
AC XY:
39
AN XY:
664264
show subpopulations
African (AFR)
AF:
0.000134
AC:
4
AN:
29758
American (AMR)
AF:
0.000140
AC:
6
AN:
42740
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24692
East Asian (EAS)
AF:
0.0000526
AC:
2
AN:
38042
South Asian (SAS)
AF:
0.0000121
AC:
1
AN:
82910
European-Finnish (FIN)
AF:
0.0000196
AC:
1
AN:
51018
Middle Eastern (MID)
AF:
0.000189
AC:
1
AN:
5292
European-Non Finnish (NFE)
AF:
0.0000644
AC:
64
AN:
994036
Other (OTH)
AF:
0.0000722
AC:
4
AN:
55428
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000746
AC:
10
AN:
134050
Hom.:
0
Cov.:
30
AF XY:
0.000110
AC XY:
7
AN XY:
63712
show subpopulations
African (AFR)
AF:
0.000116
AC:
4
AN:
34520
American (AMR)
AF:
0.00
AC:
0
AN:
12340
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4548
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4070
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7362
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
262
European-Non Finnish (NFE)
AF:
0.0000924
AC:
6
AN:
64924
Other (OTH)
AF:
0.00
AC:
0
AN:
1762
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000371
Hom.:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cardiovascular phenotype Pathogenic:1
Jan 09, 2025
Ambry Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R250C variant (also known as c.748C>T), located in coding exon 7 of the CASQ2 gene, results from a C to T substitution at nucleotide position 748. The arginine at codon 250 is replaced by cysteine, an amino acid with highly dissimilar properties. This variant has been identified in conjunction with another variant(s) in this same gene in individual(s) with features consistent with catecholaminergic polymorphic ventricular tachycardia (CPVT) and segregated with disease in at least one family (Gao L et al. Cardiol J, 2018;25:756-758). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Catecholaminergic polymorphic ventricular tachycardia 1;C2677794:Catecholaminergic polymorphic ventricular tachycardia 2 Uncertain:1
Sep 10, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
Jul 06, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 250 of the CASQ2 protein (p.Arg250Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with catecholaminergic polymorphic ventricular tachycardia (PMID: 30600839). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 572954). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Pathogenic
0.34
D
BayesDel_noAF
Pathogenic
0.25
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.79
D
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.69
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.064
D
MetaRNN
Pathogenic
0.90
D
MetaSVM
Uncertain
0.39
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
2.7
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Pathogenic
0.69
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.89
MVP
0.98
MPC
0.35
ClinPred
0.80
D
GERP RS
5.2
Varity_R
0.65
gMVP
0.88
Mutation Taster
=10/90
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.16
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151115064; hg19: chr1-116268164; COSMIC: COSV54771784; COSMIC: COSV54771784; API